59 - Developing New Activity-Based Bioassays to Screen for HIF Stabilizers - Liesl Janssens

08/03/21 • 27 min

Liesl Janssens is a PhD student in the Lab of Toxicology at Ghent University. Her virtual poster was a finalist in the PCC’s 2021 virtual poster session in the category of Pilot Studies. She is developing novel activity-based bioassays to screen for performance enhancing hypoxia-inducible factor (HIF) stabilizers. HIF stabilizers are small molecules that help to produce more blood cells by stimulating endogenous erythropoietin production. She shares more about this project and her work in this episode.

Previous Episode

58 - Cycling Benefits from New Partnership with the International Testing Agency - Olivier Banuls

Olivier Banuls served as the director for the Cycling Anti-Doping Foundation (CADF), and he is now working with the International Testing Agency (ITA) to help fight doping in cycling. He joins us in this interview to talk about the ITA and their new anti-doping efforts in the sport of cycling in collaboration with the Union Cycliste Internationale (UCI). This is the second of our two-episode mini-series taking an in-depth look at anti-doping in cycling, in conjunction with the Tour de France this month.

Next Episode

60 - Leading Rigorous Anti-Doping Efforts in Canada - Jeremy Luke

Jeremy Luke is Senior Director of Sport Integrity at the Canadian Center for Ethics in Sport (CCES), the Canadian national anti-doping organization (NADO). He also led the anti-doping program for the Vancouver Olympic and Paralympic Games in 2010. Jeremy joins us in this episode to talk about CCES, discuss how NADO’s have been dealing with the pandemic, and share his insights into what it takes to run anti-doping efforts during the Olympic and Paralympic Games.